semaglutide liver enzymes New analysis of trial of in adolescents shows it can reduce indicative of liver damage Effect of semaglutide on liver

For example, the SELECT trial reported that semaglutide reduced the risk of MACE by 20% (Hazard Ratio (HR) 0.80, 95% confidence interval (CI) 0.720.90) in people with obesity but without diabetes, although several secondary outcomes did not reach statistical significance under hierarchical testing procedures

Start by talking to your doctor, not your insurer

Xanthine oxidoreductase: One enzyme for multiple physiological tasks

Organizations need to understand not just what they spent on GLP-1s last quarter, but which members are driving utilization, whether formulary controls are working, and where costs are heading next

GLP1-RAs decrease a persons food intake